quanterix q1 earnings call highlights

Quanterix (QTRX) reported Q1 2026 earnings with revenue growth driven by a partnership with Tempus AI in Alzheimer's diagnostics. The company is investing in growth while maintaining guidance. Organic revenue declined 21% YoY, with academic customers at 65% of revenue. The commercial mechanism is weak: no direct commodity price impact, supply shortage, or margin squeeze. The partnership signals potential demand for diagnostic tools but no immediate scarcity or price effect. Sector relevance is limited to healthcare and AI diagnostics.